首页|不同剂量右美托咪定对腹腔镜子宫肌瘤剔除术患者疼痛因子、炎性反应因子和认知功能的影响

不同剂量右美托咪定对腹腔镜子宫肌瘤剔除术患者疼痛因子、炎性反应因子和认知功能的影响

扫码查看
目的 探讨不同剂量右美托咪定对腹腔镜子宫肌瘤剔除术(LM)患者疼痛因子、炎性反应因子和认知功能的影响.方法 选取2020年3月至2022年3月新乡市中心医院择期行LM的子宫肌瘤患者98例为研究对象,以随机数字表法分为低剂量组(n=32)、高剂量组(n=32)及对照组(n=34).对照组给予常规全身麻醉处理,低、高剂量组在对照组基础上分别使用0.1、0.5μg/(kg·h)右美托咪定至手术结束,比较三组在术前及术后1d、3d疼痛因子[β-内啡肽(β-EP)、去甲肾上腺素(NE)、P-物质(SP)]、炎性反应因子[白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、C反应蛋白(CRP)]和认知功能[以简易精神状态量表(MMSE)评估],比较三组术后不良反应发生率.结果 术后1d的β-EP、NE、SP、IL-6、TNF-α及CRP水平在三组间的比较均为:高剂量组<低剂量组<对照组,差异均具有统计学意义(F=9.132、14.376、62.570、42.254、37.120、36.830,P<0.05);术后3d的β-EP、NE、SP、IL-6、TNF-α及CRP水平在三组间的比较均为:高剂量组<低剂量组<对照组,差异均具有统计学意义(F=8.903、10.280、73.878、19.720、29.216、46.666,P<0.05);术后1d的MMSE量表评分比较为:高剂量组>低剂量组>对照组,差异具有统计学意义(F=81.318、17.564,P<0.05);术后3d的MMSE量表评分比较为:高剂量组>低剂量组>对照组,差异具有统计学意义(F=17.564,P<0.05);不良反应发生率在三组间相比,差异无统计学意义(P>0.05).结论 0.5 μg/kg剂量右美托咪定更能减轻LM患者疼痛及抑制患者炎性反应,促进患者术后认知功能恢复,且安全性高.
Effects of different doses of dexmedetomidine on pain factors,inflammatory factors and cognitive function in patients undergoing laparoscopic myomectomy
Objective To investigate the effects of different doses of dexmedetomidine on pain factors,inflammatory response and cognitive function in patients undergoing laparoscopic myomectomy(LM).Methods A total of 98 patients with uterine fibroids who underwent LM in Xinxiang Central Hospital from March 2020 to March 2022 were selected as the research objects.They were divided into the low-dose group(n=32),the high-dose group(n=32)and the control group(n=34)by random number table method.The control group was treated with routine general anesthesia,and the low and high dose groups were treated with 0.1 and 0.5 μg/(kg·h)dexmedetomidine respectively based on the control group until the end of the oper-ation.The pain factors[β-endorphin(β-EP),norepinephrine(NE),P-substance(SP)],inflammatory fac-tors[interleukin-6(IL-6),tumor necrosis factor-α(TNF-α),C-reactive protein(CRP)]and cognitive func-tion[assessed by mini-mental state examination(MMSE)]were compared among the three groups before op-eration and 1 and 3 days after operation.The incidence of postoperative adverse reactions was compared among the three groups.Results The comparison of β-EP,NE,SP,IL-6,TNF-α and CRP levels among the three groups 1 day after surgery was:high-dose group<low-dose group<control group,and the differences were sta-tistically significant(F=9.132,14.376,62.570,42.254,37.120,36.830,P<0.05).The comparison of β-EP,NE,SP,IL-6,TNF-α and CRP levels among the three groups on the 3rd day after surgery was as fol-lows:high-dose group<low-dose group<control group,and the differences were all statistically significant(F=8.903,10.280,73.878,19.720,29.216,46.666,P<0.05).The comparison of MMSE scale scores on the first day after operation was:high-dose group>low-dose group>control group,and the difference was sta-tistically significant(F=81.318,17.564,P<0.05).The comparison of MMSE scale scores on the 3rd day after operation was as follows:high-dose group>low-dose group>control group,and the difference was statistical-ly significant(F=17.564,P<0.05).Conclusion Dexmedetomidine at a dose of 0.5 μg/kg can reduce pain and inhibit the inflammatory response in LM patients,promote the recovery of postoperative cognitive function.

DexmedetomidineLaparoscopic myomectomyPain factorInflammatory reactionCognitive function

胡微澜、李明勇、韩威利、邵坤、豆武涛、海洋、陈胜阳

展开 >

新乡市中心医院麻醉与围术期医学科(新乡医学院第四临床学院),河南,新乡 453000

新乡医学院第一附属医院麻醉科,河南,新乡 453000

右美托咪定 腹腔镜子宫肌瘤剔除术 疼痛因子 炎性反应 认知功能

河南省医学科技攻关计划联合共建项目和软科学研究计划

LHGJ20210919

2024

分子诊断与治疗杂志
中山大学

分子诊断与治疗杂志

CSTPCD
影响因子:0.65
ISSN:1674-6929
年,卷(期):2024.16(1)
  • 1
  • 12